Department of Pneumology, Central University Teaching Hospital of Asturias, Oviedo, Spain.
Department of Preventive Medicine and Public Health, University of Santiago de Compostela, C/San Francisco s/n, 15782, Santiago de Compostela, Spain.
Sci Rep. 2022 Jan 26;12(1):1381. doi: 10.1038/s41598-022-05421-6.
It is not known whether residential radon exposure may be linked to the development of chronic obstructive pulmonary disease (COPD) and/or have an influence on the functional characteristics or exacerbations of COPD. The aim of this study was therefore to ascertain whether there might be an association between residential radon concentrations and certain characteristics of COPD. We analyzed COPD cases drawn from a case-control study conducted in an area of high radon exposure. Data were collected on spirometric pulmonary function variables, hospital admissions, and smoking. Radon measurements were taken using alpha-track-type CR-39 detectors individually placed in patients' homes. All statistical analyses were performed using the IBM SPSS v22 computer software program. The study included 189 COPD cases (79.4% men; median age 64 years). The median radon concentration was 157 Bq/m. No differences were found between radon concentration and sex, age or severity of breathing obstruction as measured by FEV1%. It should be noted, however, that 48.1% of patients with FEV1% < 50 had radon concentrations below 100 Bq/m, as compared to 35.6% with the same severity of obstruction who had over 300 Bq/m. COPD cases with radon concentrations higher than > 600 Bq/m exhibited no different characteristics in lung function. Exposure to radon does not appear to have an influence on the clinical characteristics of smokers and ex-smokers with COPD. As exposure to residential radon increases, there is no trend towards a worsening of FEV1%. Further studies are thus needed to analyze this possible association in never-smokers with COPD.
目前尚不清楚居住性氡暴露是否与慢性阻塞性肺疾病(COPD)的发展有关,以及/或者对 COPD 的功能特征或加重是否有影响。因此,本研究旨在确定居住性氡浓度与 COPD 的某些特征之间是否存在关联。我们分析了在高氡暴露地区进行的病例对照研究中抽取的 COPD 病例。收集了关于肺量计肺功能变量、住院和吸烟的数据。使用单独放置在患者家中的α径迹型 CR-39 探测器测量氡。所有统计分析均使用 IBM SPSS v22 计算机软件程序进行。该研究包括 189 例 COPD 病例(79.4%为男性;中位年龄 64 岁)。氡浓度中位数为 157 Bq/m。未发现氡浓度与性别、年龄或 FEV1% 测量的呼吸阻塞严重程度之间存在差异。然而,应当注意,48.1% FEV1% < 50 的患者的氡浓度低于 100 Bq/m,而同一严重程度阻塞的患者中,有 35.6%的患者的氡浓度超过 300 Bq/m。氡浓度高于> 600 Bq/m 的 COPD 病例在肺功能方面没有表现出不同的特征。暴露于氡似乎不会对患有 COPD 的吸烟者和前吸烟者的临床特征产生影响。随着居住性氡暴露的增加,FEV1% 没有恶化的趋势。因此,需要进一步的研究来分析从不吸烟的 COPD 患者中可能存在的这种关联。